Market Report, "Astex Pharmaceuticals, Inc. - Product Pipeline Review

2012-10-04 07:52:36 - Market Report, "Astex Pharmaceuticals, Inc. - Product Pipeline Review - 2012", published

Global Market Direct's pharmaceuticals report, "Astex Pharmaceuticals, Inc. - Product Pipeline Review - 2012" provides data on the Astex Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Astex Pharmaceuticals, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Astex Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Astex Pharmaceuticals, Inc. - Brief Astex Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline

of Astex Pharmaceuticals, Inc. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Astex Pharmaceuticals, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Astex Pharmaceuticals, Inc.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/468508_astex_pharmaceuticals_inc_product_pip ..

Reasons to buy

* Evaluate Astex Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Astex Pharmaceuticals, Inc. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Astex Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Astex Pharmaceuticals, Inc..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Astex Pharmaceuticals, Inc. and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Astex Pharmaceuticals, Inc. Snapshot
Astex Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Astex Pharmaceuticals, Inc. - Research and Development Overview
Key Therapeutic Areas
Astex Pharmaceuticals, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Astex Pharmaceuticals, Inc. - Pipeline Products Glance
Astex Pharmaceuticals, Inc. - Late Stage Pipeline
Filing Rejected/Withdrawn Products/Combination Treatment Modalities
Astex Pharmaceuticals, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Astex Pharmaceuticals, Inc. - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Astex Pharmaceuticals, Inc. - Drug Profiles
amuvatinib
Product Description
Mechanism of Action
R&D Progress
Amuvatinib + Carboplatin
Product Description
Mechanism of Action
R&D Progress
Amuvatinib + Docetaxel
Product Description
Mechanism of Action
R&D Progress
Amuvatinib + Erlotinib
Product Description
Mechanism of Action
R&D Progress
Amuvatinib + Paclitaxel
Product Description
Mechanism of Action
R&D Progress
Amuvatinib + Topotecan
Product Description
Mechanism of Action
R&D Progress
AT-13148
Product Description
Mechanism of Action
R&D Progress
AT-13387
Product Description
Mechanism of Action
R&D Progress
AT-26893
Product Description
Mechanism of Action
R&D Progress
AT-7519
Product Description
Mechanism of Action
R&D Progress
AT-9283
Product Description
Mechanism of Action
R&D Progress
AT13387 + Imatinib
Product Description
Mechanism of Action
R&D Progress
AT7519 + Bortezomib
Product Description
Mechanism of Action
R&D Progress
AT9283 + Docetaxel
Product Description
Mechanism of Action
R&D Progress
AT9283 + Lenalidomide
Product Description
Mechanism of Action
R&D Progress
AXL Kinase Inhibitor
Product Description
Mechanism of Action
R&D Progress
Drug For Multiple Therapeutic Targets
Product Description
Mechanism of Action
R&D Progress
ETK/BMX Inhibitors
Product Description
Mechanism of Action
R&D Progress
MetAP2 Program
Product Description
Mechanism of Action
R&D Progress
MP-529
Product Description
Mechanism of Action
R&D Progress
paclitaxel
Product Description
Mechanism of Action
R&D Progress
RNaseH Inhibitor
Product Description
Mechanism of Action
R&D Progress
rubitecan
Product Description
Mechanism of Action
R&D Progress
SGI-110
Product Description
Mechanism of Action
R&D Progress
SGI-1252
Product Description
Mechanism of Action
R&D Progress
SGI-1551
Product Description
Mechanism of Action
R&D Progress
Tumour Cell Metabolism Program
Product Description
Mechanism of Action

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468508&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.